{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:19:05Z","timestamp":1789510745962,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T00:00:00Z","timestamp":1737244800000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.radonc.2024.110093","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T18:05:31Z","timestamp":1705169131000},"page":"110093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients \u2013 A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia"],"prefix":"10.1016","volume":"192","author":[{"given":"Grace C.","family":"Blitzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Glassey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga R.","family":"Ganz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayeeta","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pennati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross O.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber M.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangok P","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Mattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Croxford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany A.","family":"Glazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Rogus-Pulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Galipeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Kimple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110093_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2013.11.010","article-title":"Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis","volume":"110","author":"Marta","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110093_b0010","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-22-2875","article-title":"FDA approval summary: Lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer","volume":"29","author":"Fallah","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2024.110093_b0015","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1742-1241.2009.02132.x","article-title":"Managing the patient presenting with xerostomia: a review","volume":"64","author":"Visvanathan","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.radonc.2024.110093_b0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tripleo.2004.04.009","article-title":"Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer","volume":"98","author":"Gornitsky","year":"2004","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.radonc.2024.110093_b0025","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s00296-011-2085-6","article-title":"Evaluation of the clinical efficacy of Biotene Oral Balance in patients with secondary Sjogren's syndrome: a pilot study","volume":"32","author":"Aliko","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.radonc.2024.110093_b0030","first-page":"319","article-title":"A double-blind, crossover study of Biotene Oralbalance and BioXtra systems as salivary substitutes in patients with post-radiotherapy xerostomia","volume":"14","author":"Shahdad","year":"2005","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.radonc.2024.110093_b0035","first-page":"824","article-title":"The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies","volume":"4","author":"Romieu-Mourez","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.radonc.2024.110093_b0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.radonc.2024.110093_b0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.299.8.925","article-title":"Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases","volume":"299","author":"Burt","year":"2008","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2024.110093_b0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.stemcr.2015.11.009","article-title":"Long-term in vitro expansion of salivary gland stem cells driven by Wnt signals","volume":"6","author":"Maimets","year":"2016","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.radonc.2024.110093_b0055","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1172\/JCI74096","article-title":"Neurotrophic factor GDNF promotes survival of salivary stem cells","volume":"124","author":"Xiao","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.radonc.2024.110093_b0060","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.oooo.2013.11.496","article-title":"Mesenchymal stem cell therapy for salivary gland dysfunction and xerostomia: a systematic review of preclinical studies","volume":"117","author":"Jensen","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.radonc.2024.110093_b0065","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2011-11-391144","article-title":"Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome","volume":"120","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2024.110093_b0070","doi-asserted-by":"crossref","first-page":"e38615","DOI":"10.1371\/journal.pone.0038615","article-title":"Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with Sj\u00f6gren's-like disease","volume":"7","author":"Khalili","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2024.110093_b0075","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/lary.22080","article-title":"Regeneration of radiation damaged salivary glands with adipose-derived stromal cells","volume":"121","author":"Kojima","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2024.110093_b0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.oraloncology.2012.08.010","article-title":"Intraglandular transplantation of bone marrow-derived clonal mesenchymal stem cells for amelioration of post-irradiation salivary gland damage","volume":"49","author":"Lim","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110093_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/0022034510386374","article-title":"Cell therapy for salivary gland regeneration","volume":"90","author":"Lin","year":"2011","journal-title":"J Dent Res"},{"key":"10.1016\/j.radonc.2024.110093_b0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13287-023-03301-y","article-title":"Efficacy of mesenchymal stem cell therapy in rodent models of radiation-induced xerostomia and oral mucositis: a systematic review","volume":"14","author":"Guan","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.radonc.2024.110093_b0095","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijrobp.2018.02.034","article-title":"Safety and efficacy of mesenchymal stem cells for radiation-induced xerostomia: A randomized, placebo-controlled phase 1\/2 trial (MESRIX)","volume":"101","author":"Gronhoj","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110093_b0100","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0301-472X(99)00076-4","article-title":"Stromal damage as consequence of high-dose chemo\/radiotherapy in bone marrow transplant recipients","volume":"27","author":"Galotto","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.radonc.2024.110093_b0105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/scd.2007.0008","article-title":"Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases","volume":"16","author":"Zhao","year":"2007","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.radonc.2024.110093_b0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1203\/01.PDR.0000099773.71438.91","article-title":"Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children","volume":"55","author":"Corazza","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.radonc.2024.110093_b0115","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/stcltm\/szac011","article-title":"Intraglandular off-the-shelf allogeneic mesenchymal stem cell treatment in patients with radiation-induced xerostomia: A safety study (MESRIX-II)","volume":"11","author":"Lynggaard","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.radonc.2024.110093_b0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","article-title":"International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials","volume":"18","author":"Galipeau","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.radonc.2024.110093_b0125","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/stem.2415","article-title":"Cryopreserved mesenchymal stromal cells are susceptible to T-cell mediated apoptosis which is partly rescued by IFNgamma licensing","volume":"34","author":"Chinnadurai","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.radonc.2024.110093_b0130","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/bloodadvances.2017006205","article-title":"Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNgamma priming","volume":"1","author":"Chinnadurai","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.radonc.2024.110093_b0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ebiom.2018.01.002","article-title":"Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-gamma","volume":"28","author":"Kim","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.radonc.2024.110093_b0140","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/mt.2015.67","article-title":"Mesenchymal stromal cells derived from Crohn's patients deploy indoleamine 2,3-dioxygenase-mediated immune suppression, independent of autophagy","volume":"23","author":"Chinnadurai","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.radonc.2024.110093_b0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-60761-999-4_25","article-title":"Phenotypic analysis and differentiation of murine mesenchymal stem cells","volume":"698","author":"da Silva","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.radonc.2024.110093_b0150","article-title":"A method for the measurement of salivary gland function in mice","volume":"131","author":"Bagavant","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.radonc.2024.110093_b0155","doi-asserted-by":"crossref","unstructured":"Nickel K, Paz C, Kimple R. Saliva Collection: Protocols.io; 2024.","DOI":"10.17504\/protocols.io.q26g7pxr8gwz\/v1"},{"key":"10.1016\/j.radonc.2024.110093_b0160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.2004.05200.x","article-title":"Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents","volume":"127","author":"Li","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.radonc.2024.110093_b0165","first-page":"310","article-title":"Effects of radiation on hematopoietic stroma","volume":"4","author":"Fried","year":"1976","journal-title":"Exp Hematol"},{"key":"10.1016\/j.radonc.2024.110093_b0170","doi-asserted-by":"crossref","first-page":"87809","DOI":"10.18632\/oncotarget.21214","article-title":"Cisplatin radiosensitizes radioresistant human mesenchymal stem cells","volume":"8","author":"R\u00fchle","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2024.110093_b0175","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3727\/096368917X694886","article-title":"Cisplatin-impaired adipogenic differentiation of adipose mesenchymal stem cells(1)","volume":"26","author":"Chang","year":"2017","journal-title":"Cell Transplant"},{"key":"10.1016\/j.radonc.2024.110093_b0180","doi-asserted-by":"crossref","first-page":"20035","DOI":"10.1038\/srep20035","article-title":"Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin","volume":"6","author":"Nicolay","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2024.110093_b0185","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.radonc.2024.110093_b0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00262-014-1623-y","article-title":"Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells","volume":"64","author":"Andre","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.radonc.2024.110093_b0195","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.leu.2404466","article-title":"Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma","volume":"21","author":"Arnulf","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.radonc.2024.110093_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcmgh.2015.12.004","article-title":"Foxl1-expressing mesenchymal cells constitute the intestinal stem cell niche","volume":"2","author":"Aoki","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.radonc.2024.110093_b0205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41586-018-0190-3","article-title":"GLI1-expressing mesenchymal cells form the essential Wnt-secreting niche for colon stem cells","volume":"558","author":"Degirmenci","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2024.110093_b0210","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1038\/s41467-019-12349-5","article-title":"R-spondin 3 promotes stem cell recovery and epithelial regeneration in the colon","volume":"10","author":"Harnack","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2024.110093_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by mesenchymal stem cells (MSCs): Mechanisms of action of living, apoptotic, and dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2024.110093_b0220","doi-asserted-by":"crossref","first-page":"3057624","DOI":"10.1155\/2018\/3057624","article-title":"Mesenchymal stem cell-based immunomodulation: Properties and clinical application","volume":"2018","author":"Wang","year":"2018","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.radonc.2024.110093_b0225","doi-asserted-by":"crossref","DOI":"10.1002\/stem.3380","article-title":"Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity","author":"Galipeau","year":"2021","journal-title":"Stem Cells"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:11Z","timestamp":1759123631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":45,"alternative-id":["S0167814024000148"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110093","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients \u2013 A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110093"}}